UBS O'Connor’s Cartesian Growth Corporation II Unit RENEU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-551,483
Closed -$5.52M 1039
2022
Q3
$5.52M Sell
551,483
-55,208
-9% -$554K 0.06% 197
2022
Q2
$6.07M Buy
+606,691
New +$6.06M 0.06% 194

Other funds holding RENEU

UBS O'Connor's RENEU Position: Q4 2022 in Review

UBS O'Connor sold out of Cartesian Growth Corporation II Unit (RENEU) in Q4 2022, closing a stake of 551,483 shares — an estimated $5.52M sold.

UBS O'Connor first reported a position in RENEU in Q2 2022 and held it in 2 quarters. The position peaked at $6.07M in Q2 2022. 15 funds tracked by Wall St. Rank hold RENEU as of Q4 2022.

  • UBS O'Connor reported no remaining Cartesian Growth Corporation II Unit position as of Q4 2022 after selling out during the quarter.
  • UBS O'Connor sold 551,483 Cartesian Growth Corporation II Unit shares in Q4 2022, an estimated $5.52M.
  • UBS O'Connor first reported a position in Cartesian Growth Corporation II Unit in Q2 2022 and held it in 2 quarters.
  • UBS O'Connor's Cartesian Growth Corporation II Unit position peaked at $6.07M in Q2 2022.
  • 15 funds tracked by Wall St. Rank held Cartesian Growth Corporation II Unit as of Q4 2022.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.